LIZHI INC. to Report Fourth Quarter and Fiscal Year 2022

LIZHI INC. to Report Fourth Quarter and Fiscal Year 2022

Earnings Call Scheduled for 7:00 a.m. ET on March 16, 2023......

Himax Technologies, Inc. to Attend 26th Credit Suisse Asian

Himax Technologies, Inc. to Attend 26th Credit Suisse Asian

TAINAN, Taiwan, March 06, 2023 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless......

Additional Data on Lumos OraGrowtH Trials Presented

Additional Data on Lumos OraGrowtH Trials Presented

Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data Analysis Baseline Characteristics......

GDS to Report Fourth Quarter and Full Year 2022 Financial

GDS to Report Fourth Quarter and Full Year 2022 Financial

SHANGHAI, China, March 05, 2023 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading......

89bio Presents New Analysis of Data from Phase 2 ENTRIGUE

89bio Presents New Analysis of Data from Phase 2 ENTRIGUE

– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG......

Cytokinetics Presents Positive Results From Cohort 4 of

Cytokinetics Presents Positive Results From Cohort 4 of

Treatment with Aficamten Resulted in Significant Improvements in Heart Failure Symptoms and Cardiac Biomarkers in Patients with Non-Obstructive......

The RealReal Announces Inducement Grants under Nasdaq

The RealReal Announces Inducement Grants under Nasdaq

SAN FRANCISCO, March 03, 2023 (GLOBE NEWSWIRE) -- The RealReal, Inc. (NASDAQ: REAL) – the world’s largest online marketplace for authenticated, resale......

Praxis Precision Medicines to Present at Upcoming Investor

Praxis Precision Medicines to Present at Upcoming Investor

BOSTON, March 03, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating......

Impel Pharmaceuticals to Participate in Upcoming Investor

Impel Pharmaceuticals to Participate in Upcoming Investor

SEATTLE, March 03, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing......

Cumulus Media’s Westwood One Presents Audio Coverage of

Cumulus Media’s Westwood One Presents Audio Coverage of

Coverage Includes 23 Games between Saturday, March 4th and Sunday, March 12th, 2023......

  • 1
  • ...
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • ...
  • 44
  • menu
    menu